Fully regulated UK pharmacy
Safe & clinically reviewed care
Rated 4.9/5 from over 3,000 reviews
Fast, discreet delivery

Mysimba offers a unique solution to getting to a healthier weight by working directly on hunger signals in the brain. Unlike other weight loss treatments, it is available as an oral tablet, and does not work on the gut itself.
Containing two active ingredients, naltrexone and bupropion, Mysimba is licensed for use by eligible patients, and available from our GPhC registered online clinic.
As a prescription treatment, to purchase Mysimba you will need to fill out an online consultation, prior to adding to your basket.
Following approval, all medication is packaged securely in plain, discreet packaging and delivered straight to your door with next day delivery options available.
As a GPhC registered pharmacy, at Quick Meds we source all medications from MHRA-accredited suppliers, ensuring all medication is legitimate.
To place an order, head to our website, to the weight loss section. Hit the start consultation button, and fill out the whole form accurately.
The form will ask questions about your weight, your general health along with medical history and if you take any other medication. Once complete, you will be able to add Mysimba to your basket and checkout.
Our registered clinicians will review your responses for clinical suitability and safety. Clinicians may also request additional information, by accessing your NHS health record or fully-clothed body images to verify your weight.
Once approved, orders are packaged appropriately and dispatched usually on the same day with delivery options as soon as the next working day.
Mysimba is a prescription-only (POM) weight loss treatment containing the active ingredients naltrexone and bupropion. It works by controlling hunger signals directly in the brain and reducing the pleasure associated with eating food.
Weight loss is not immediately apparent with Mysimba. As it affects nerve centres in the brain, it's essential to gradually increase the dose every week.
Appetite suppression and reduction in food cravings can begin within the first few weeks, but significant weight loss is not expected until the maintenance dose has been reached and continued for several weeks.
Available in 8mg/90mg prolonged release tablets, the dose is titrated up from one tablet daily to the maintenance dose of two tablets, twice daily.
Effectiveness of Mysimba was assessed across four clinical trials (COR-I, COR-II, COR-BMOD, COR-diabetes) evaluating over 4,500 subjects. Trials were randomised and assigned to Mysima or placebo. Primary outcomes were measured over 56 weeks and found:
Trial | Population | Mysimba weight loss | Placebo weight loss |
|---|---|---|---|
Obese/overweight | -6.1% | -1.3% | |
Obese/overweight | -6.4% | -1.2% | |
Intense lifestyle modification | -9.3% | -5.1% | |
Patients with Type 2 Diabetes | -5.0% | -1.8% |
COR-I - measured the effect of the treatment on weight loss in overweight and obese adults
COR-II - measured the effect on weight loss and weight-related risk factors
COR-BMOD - measured the effect in combination with behaviour modification
COR-Diabetes - measured the effect on both weight and blood sugar levels in diabetic patients.
In all four trials, Mysimba led to a greater weight loss compared to placebo. The most common side effects were:
Nausea
Constipation
Dizziness
Insomnia
Dry mouth
Headache.
In COR-I, 49% of participants dropped out and did not complete the full 56 weeks due to nausea. Data from these trials show, whilst the treatment is effective, it may not suit everyone.
Mysimba is taken as oral tablets, with the dose increasing gradually over 4-weeks as follows:
Week 1 - One tablet in the morning
Week 2 - One in the morning and one in the evening
Week 3 - Two in the morning and one in the evening
Week 4 - Two in the morning and two in the evening
The maximum recommended dose is four tablets daily. If a dose is missed, an additional dose should not be taken, but take the next dose at the usual time.
The tablets should be swallowed whole with water and should not be cut, chewed, or crushed. Tablets should be taken with meals but avoiding very high-fat meals.
Mysimba is indicated for weight loss, in adults over 18, with an initial Body Mass Index (BMI) of
30 or over - Obese
Between 27 and 30 - overweight, with a weight-related health condition (type 2 diabetes, controlled high blood pressure)
The treatment is indicated for use alongside lifestyle changes such as:
A reduced calorie diet
Increased physical activity
Whilst safe for use by most, Mysimba must not be taken by:
The elderly - over 75 years
Children and adolescents - under 18 years
End stage kidney disease
Severe liver disease
A known tumour of the central nervous system
A history of bipolar disorder
A current or previous diagnosis of bulimia or anorexia
A dependence on chronic opioids - such as codeine
Alcohol dependence
Allergies to the active ingredients or any of the excipients.
Uncontrolled high blood pressure
During pregnancy or breastfeeding
Mysimba can interact with certain medication and must not be taken with:
Opioids - painkillers containing codeine, morphine, fentanyl or oxycodone
MAOIs - used for depression or Parkinson’s.
Additionally, Mysimba can affect the levels of the following, making them too strong or too weak:
Antidepressants - specifically SSRIs, such as sertraline, fluoxetine, citalopram
Blood pressure & heart medicines - specifically Beta-blockers (bisoprolol, atenolol)
Tamoxifen - breast cancer medication which may be less effective if taken with Mysimba
Diabetic medicines - combined with Mysimba may cause hypoglycaemia
Mysimba can lower the seizure threshold. Caution is needed if you take other medications which also have this risk, such as oral steroids, tramadol or quinolone antibiotics.
Whilst not a direct interaction, drinking alcohol with Mysimba can lead to neuropsychotic side effects. It is recommended to avoid alcohol whilst on treatment.
The treatment should always be taken with food. It works best when taken with a meal though avoid high-fat meals to prevent side effects.
As with all medicines, Mysimba can cause side effects, though not everyone gets them. These are more likely in the first few weeks of treatment as the body is adjusting to treatment.
The most common side effects can affect 1 in 10 people who use this medicine and include:
Nausea
Constipation
Diarrhoea
Headache
Vomiting
Dizziness
Trouble sleeping (insomnia)
Dry mouth
Lifestyle modifications, such as ensuring adequate hydration and eating plenty of fibre can help manage most of the common side effects whilst also helping with weight loss.
Less common side effects can affect 1 in 100 people and include:
Anxiety
Insomnia (difficulty sleeping)
Tremors (feeling shaky)
Dysgeusia (a bad or unpleasant taste in the mouth)
Lethargy (tiredness)
Somnolence (sleepiness)
Tinnitus (ringing in the ears)
Palpitations (irregular heart beat) or a higher-than-usual heart rate
Flushing or suddenly feeling hot
Pain or aches in the tummy
Hyperhidrosis (sweating more than usual)
Pruritus (itchy skin)
Alopecia (hair falling out)
The patient information leaflet, included with the treatment includes a comprehensive list of side effects.
Serious side effects are rare, affecting 1 in 1,000 to 10,000 people and include:
Suicidal thoughts, or thoughts of self harm
Fits or seizures,
Loss of consciousness (fainting)
Stevens-Johnson Syndrome or Erythema Multiforme, e.g. itchy red spots, starting on the arms and legs, severe blisters, bleeding on the lips, eyes, mouth, nose, or genitals
Rhabdomyolysis, e.g. severe muscle cramps, pain or weakness, affecting any part of the body
Severe allergic reaction, e.g. difficulty swallowing/breathing, pain in the muscles or joints, itching, hives, a rash that appears red on white skin, dizziness, fever, swelling of the face, tongue, mouth or throat
Increases in blood pressure or heart rate
Hepatitis e.g. stomach area pain lasting more than a few days, dark urine, yellowing of the whites of your eyes, or tiredness
Manic episodes
Visual problems (symptoms of angle-closure glaucoma include eye pain, changes in vision, swelling, or redness in or around the eye)
Hypoglycaemia (low blood sugar) in diabetic patients
If you experience any of these side effects, you should seek immediate medical attention, by calling 999 or going to the nearest A&E immediately.
Everything you need to know
Mysimba is a prescription weight loss tablet that helps reduce appetite and food cravings. It contains naltrexone and bupropion and is used alongside lifestyle changes.
Yes. Mysimba is approved in the UK and regulated by the MHRA.
Mysimba may be available through NHS specialist weight management services, but access is limited and usually requires a GP referral.
Mysimba is usually prescribed to adults with obesity or those who are overweight with weight related health conditions, based on body mass index and clinical assessment.
Mysimba works on areas of the brain that control hunger and cravings, helping people eat less and stick to a reduced calorie diet.
Mysimba typically supports moderate, gradual weight loss when combined with healthy eating and physical activity. Results vary between individuals.
Mysimba may reduce appetite within the first few weeks, but noticeable weight loss usually develops over several months.
Common side effects include nausea, constipation, headache, dizziness, dry mouth, and difficulty sleeping, especially when starting treatment.
Mysimba is considered safe when prescribed and monitored by a healthcare professional, but it is not suitable for everyone.
If you stop Mysimba, appetite and cravings may return and weight regain is possible without ongoing lifestyle changes.
Alcohol is not banned, but it may increase side effects such as dizziness or nausea, so moderation is advised.
Mysimba can interact with SSRIs and tricyclic antidepressants and should not be taken together. If you are unsure which type of medication you are on, contact our clinicians for advice.
If a dose is missed, skip this dose and take the next dose at the scheduled time. Do not double up to make up for a missed dose.
When taken with food, Mysimba works much more effectively though it should not be taken with a meal very high in fat.
Whilst it can be taken alongside simple painkillers like paracetamol or ibuprofen, if you take opioid painkillers, such as co-codamol, morphine, fentanyl, you should not use Mysimba.
If Mysimba doesn’t suit you, you can consider the weight loss injections Wegovy or Mounjaro.
Wegovy tablets are also in the final stages of approval, whilst not available yet, they will be an alternative treatment for those who do not like injections.
Privately, Mysimba usually costs a few hundred pounds per month. NHS prescriptions, where available, may reduce the cost.
Mysimba can be used long term under medical supervision, depending on individual response and health goals.